R Manzano-Nunez1,2, M F Escobar-Vidarte3, M P Naranjo4,5, F Rodriguez5, P Ferrada6, J D Casallas4,3, C A Ordoñez5,7. 1. Clinical Research Center, Fundación Valle del Lili, Cra 98 # 18-49, Cali, Colombia. ramiro.manzano@correounivalle.edu.co. 2. Division of Trauma and Acute Care Surgery, Fundación Valle del Lili, Cali, Colombia. ramiro.manzano@correounivalle.edu.co. 3. Division of Obstetrics and Gynecology, Fundación Valle del Lili, Cali, Colombia. 4. Clinical Research Center, Fundación Valle del Lili, Cra 98 # 18-49, Cali, Colombia. 5. Division of Trauma and Acute Care Surgery, Fundación Valle del Lili, Cali, Colombia. 6. Department of Surgery and Surgical Critical Care Fellowship Program, Virginia Commonwealth University, Richmond, USA. 7. Department of Surgery, Trauma and Acute Care Surgery Fellowship, Universidad del Valle, Cali, Colombia.
Abstract
PURPOSE: Prophylactic placement of endovascular balloon occlusion catheters has grown to be part of the surgical plans to control intraoperative hemorrhage in cases of abnormal placentation. We performed a systematic literature review to investigate the safety and effectiveness of the use of REBOA during cesarean delivery in pregnant woman with morbidly adherent placenta. METHODS: A systematic review was performed. Relevant case reports and nonrandomized studies were identified by the literature search in MEDLINE. We included studies involving pregnant woman with diagnosis of abnormal placentation who underwent cesarean delivery with REBOA placed for hemorrhage control. MINORS' criteria were used to evaluate the risk of bias of included studies. A formal meta-analysis was not performed. RESULTS: Eight studies were included in cumulative results. These studies included a total of 392 patients. Overall, REBOA was deployed in 336 patients. Six studies reported the use of REBOA as an adjunct for prophylactic hemorrhage control in pregnant woman with diagnosis of morbidly adherent placenta undergoing elective cesarean delivery. In two studies, REBOA was deployed in patients already in established hemorrhagic shock at the moment of cesarean delivery. REBOA was deployed primarily by interventional radiologists; however, one study reported a surgeon as the REBOA provider. The results from our qualitative synthesis indicate that the use of REBOA during cesarean delivery resulted in less blood loss with a low rate complications occurrence. CONCLUSION: REBOA is a feasible, safe, and effective means of prophylactic and remedial hemorrhage control in pregnant women with abnormal placentation undergoing cesarean delivery.
PURPOSE: Prophylactic placement of endovascular balloon occlusion catheters has grown to be part of the surgical plans to control intraoperative hemorrhage in cases of abnormal placentation. We performed a systematic literature review to investigate the safety and effectiveness of the use of REBOA during cesarean delivery in pregnant woman with morbidly adherent placenta. METHODS: A systematic review was performed. Relevant case reports and nonrandomized studies were identified by the literature search in MEDLINE. We included studies involving pregnant woman with diagnosis of abnormal placentation who underwent cesarean delivery with REBOA placed for hemorrhage control. MINORS' criteria were used to evaluate the risk of bias of included studies. A formal meta-analysis was not performed. RESULTS: Eight studies were included in cumulative results. These studies included a total of 392 patients. Overall, REBOA was deployed in 336 patients. Six studies reported the use of REBOA as an adjunct for prophylactic hemorrhage control in pregnant woman with diagnosis of morbidly adherent placenta undergoing elective cesarean delivery. In two studies, REBOA was deployed in patients already in established hemorrhagic shock at the moment of cesarean delivery. REBOA was deployed primarily by interventional radiologists; however, one study reported a surgeon as the REBOA provider. The results from our qualitative synthesis indicate that the use of REBOA during cesarean delivery resulted in less blood loss with a low rate complications occurrence. CONCLUSION: REBOA is a feasible, safe, and effective means of prophylactic and remedial hemorrhage control in pregnant women with abnormal placentation undergoing cesarean delivery.
Authors: Matthew E Kutcher; Jason L Sperry; Matthew R Rosengart; Deepika Mohan; Marcus K Hoffman; Matthew D Neal; Louis H Alarcon; Gregory A Watson; Juan Carlos Puyana; Graciela M Bauzá; Vaishali D Schuchert; Anisleidy Fombona; Tianhua Zhou; Samuel J Zolin; Robert D Becher; Timothy R Billiar; Raquel M Forsythe; Brian S Zuckerbraun; Andrew B Peitzman Journal: J Trauma Acute Care Surg Date: 2017-02 Impact factor: 3.313
Authors: Jerasimos Ballas; Andrew D Hull; Cheryl Saenz; Carri R Warshak; Anne C Roberts; Robert R Resnik; Thomas R Moore; Gladys A Ramos Journal: Am J Obstet Gynecol Date: 2012-06-11 Impact factor: 8.661
Authors: Chadwick E Huggins; Michael J Gillespie; Walter A Tan; Robert C Laundon; Frederick M Costello; Shane B Darrah; David A Tate; Mauricio G Cohen; George A Stouffer Journal: J Invasive Cardiol Date: 2009-03 Impact factor: 2.022
Authors: Christina M Theodorou; Tanya N Rinderknecht; Eugenia Girda; Joseph M Galante; Rachel M Russo Journal: J Trauma Acute Care Surg Date: 2022-01-01 Impact factor: 3.313
Authors: Carlos A Ordoñez; Michael W Parra; Yaset Caicedo; Natalia Padilla; Fernando Rodríguez-Holguín; José Julián Serna; Alexander Salcedo; Alberto García; Claudia Orlas; Luis Fernando Pino; Ana Milena Del Valle; David Mejia; Juan Carlos Salamea-Molina; Megan Brenner; Tal Hörer Journal: Colomb Med (Cali) Date: 2020-12-30
Authors: John C Kingdom; Sebastian R Hobson; Ally Murji; Lisa Allen; Rory C Windrim; Evelyn Lockhart; Sally L Collins; Hooman Soleymani Majd; Moiad Alazzam; Feras Naaisa; Alireza A Shamshirsaz; Michael A Belfort; Karin A Fox Journal: Am J Obstet Gynecol Date: 2020-01-30 Impact factor: 8.661
Authors: Ramiro Manzano-Nunez; Maria F Escobar-Vidarte; Claudia P Orlas; Juan P Herrera-Escobar; Samuel M Galvagno; Juan J Melendez; Natalia Padilla; Justin C McCarty; Albaro J Nieto; Carlos A Ordoñez Journal: World J Emerg Surg Date: 2018-09-24 Impact factor: 5.469